1PERRILLO R, SCHIFF E, YOSHIDA E, et al. Adefovir dipivolxil for the treatment of lamivudine-resistant hepatitis B mutants[J]. Hepatology, 2000, 32 (1): 129-134. 被引量：1
2LAI CL, CHIEN RN, LEUNG NWY, et al. A one year trail of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998, 339(2) :61-68. 被引量：1
3LAU DT, KHOKHAR F, DOO E, et al. Long-Term therapy of chronic hepatitis B with lamivudine [J]. Hepatology, 2000, 32(4):828-834. 被引量：1
4BOCK CT, TILLMANN HL, TORRESI J. Selection of hepatitis B vires polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation [J]. Gastroenterology,2002, 122(2) :264-273. 被引量：1
5XIONG X, YANG H, WESTLAND CE, et al. In vitro evaluation of hepatitis B vires polymerase mutations associated with famciclovir resistance[J]. Hepatology, 2000,31(1) :219-224. 被引量：1
6WOLTERS LM, NIESTERS HG, Hansen BE, et al. Development of hepatitis B vires resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency vires in a Dutch cohort[J]. J Clin Virol, 2002,24(3):173-181. 被引量：1
7XIONG X, FLORES C, YANG H, et al. Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro [J]. Hepatology, 1998, 28(6): 1669-1673. 被引量：1
8NICHOLL AJ, COLLEDGE DL, TOOLE J J, et al. Inhibition of duck hepatitis B vires replication by 9-( 2-phosphonylmethoxyethyl) adenine, ana cyclic phosphonate nucleoside analogue[J]. Amimicrob Agents Chemother, 1998, 42(12): 3130-3135. 被引量：1
9WOLTERS LM, NIESTERS HG, de MAN RA, et al. Nucleoside analogues for chronic hepatitis B [J]. Eur J Gastroenterol Hepatol, 2001, 13 (12): 1499-1506. 被引量：1
10Le GUERHIER F, THERMET A, GUERRET S, et al. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model [J]. J Hepatol, 2003, 38(3) :328-334. 被引量：1
